Premium
p16 INK4a —Is the future of cervical cancer screening rosy?
Author(s) -
Moriarty Ann T.
Publication year - 2012
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.21206
Subject(s) - papanicolaou stain , medicine , cervical cancer , triage , papanicolaou test , meta analysis , cancer , oncology , psychiatry
The author comments on a meta‐analysis in this issue regarding cyclin‐dependent kinase inhibitor 2A (p16 INK4a ) and the triage of women who have minimally abnormal Papanicolaou tests. The meta‐analysis provides a framework for future research; however, the method is not currently ready for widespread clinical use.